News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
397,149 Results
Type
Article (31974)
Company Profile (58)
Press Release (365117)
Section
Business (112952)
Career Advice (1323)
Deals (24056)
Drug Delivery (93)
Drug Development (59725)
Employer Resources (104)
FDA (9943)
Job Trends (9093)
News (211700)
Policy (25513)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 Pharm Country Premier (1)
Academia (1838)
Accelerated approval (3)
Adcomms (20)
Allergies (65)
Alliances (42255)
ALS (58)
Alzheimer's disease (1092)
Antibody-drug conjugate (ADC) (89)
Approvals (9947)
Artificial intelligence (147)
Autoimmune disease (15)
Automation (6)
Bankruptcy (236)
Best Places to Work (7695)
BIOSECURE Act (15)
Biosimilars (79)
Biotechnology (42)
Bladder cancer (45)
Brain cancer (26)
Breast cancer (174)
Cancer (1498)
Cardiovascular disease (121)
Career advice (1111)
Career pathing (19)
CAR-T (102)
Cell therapy (286)
Cervical cancer (16)
Clinical research (48122)
Collaboration (643)
Compensation (379)
Complete response letters (19)
COVID-19 (2473)
CRISPR (29)
C-suite (104)
Cystic fibrosis (56)
Data (1427)
Decentralized trials (1)
Denatured (9)
Depression (35)
Diabetes (203)
Diagnostics (3555)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (33)
Drug discovery (81)
Drug pricing (95)
Drug shortages (28)
Duchenne muscular dystrophy (76)
Earnings (40302)
Editorial (32)
Employer branding (13)
Employer resources (94)
Events (45629)
Executive appointments (295)
FDA (10734)
Featured Employer (18)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (443)
Gene editing (71)
Generative AI (12)
Gene therapy (220)
GLP-1 (672)
Government (4071)
Grass and pollen (4)
Guidances (34)
Healthcare (11417)
Huntington's disease (18)
IgA nephropathy (20)
Immunology and inflammation (78)
Indications (21)
Infectious disease (2604)
Inflammatory bowel disease (76)
Inflation Reduction Act (7)
Influenza (49)
Intellectual property (67)
Interviews (231)
IPO (10434)
IRA (40)
Job creations (1758)
Job search strategy (957)
Kidney cancer (7)
Labor market (15)
Layoffs (272)
Leadership (7)
Legal (7052)
Liver cancer (49)
Lung cancer (217)
Lymphoma (101)
Machine learning (4)
Management (32)
Manufacturing (205)
MASH (51)
Medical device (5935)
Medtech (5936)
Mergers & acquisitions (13989)
Metabolic disorders (559)
Multiple sclerosis (51)
NASH (20)
Neurodegenerative disease (66)
Neuropsychiatric disorders (22)
Neuroscience (1457)
NextGen: Class of 2025 (3663)
Non-profit (2770)
Northern California (1537)
Now hiring (4)
Obesity (320)
Opinion (190)
Ovarian cancer (52)
Pain (47)
Pancreatic cancer (63)
Parkinson's disease (105)
Partnered (12)
Patents (145)
Patient recruitment (55)
Peanut (38)
People (24928)
Pharmaceutical (18)
Pharmacy benefit managers (10)
Phase I (14542)
Phase II (20906)
Phase III (16954)
Pipeline (831)
Podcasts (38)
Policy (104)
Postmarket research (1851)
Preclinical (6015)
Press Release (28)
Prostate cancer (73)
Psychedelics (28)
Radiopharmaceuticals (204)
Rare diseases (257)
Real estate (2582)
Recruiting (44)
Regulatory (16080)
Reports (22)
Research institute (1591)
Resumes & cover letters (195)
Rett syndrome (3)
RNA editing (3)
RSV (44)
Schizophrenia (59)
Series A (72)
Series B (38)
Service/supplier (4)
Sickle cell disease (38)
Southern California (1262)
Special edition (5)
Spinal muscular atrophy (137)
Sponsored (18)
Startups (1887)
State (1)
Stomach cancer (11)
Supply chain (47)
The Weekly (28)
United States (12563)
Vaccines (687)
Venture capitalists (24)
Webinars (5)
Weight loss (240)
Women's health (13)
Worklife (9)
Date
Today (74)
Last 7 days (466)
Last 30 days (1844)
Last 365 days (21506)
2025 (5303)
2024 (22365)
2023 (25272)
2022 (33408)
2021 (35915)
2020 (34104)
2019 (27936)
2018 (21254)
2017 (20208)
2016 (18712)
2015 (21507)
2014 (15961)
2013 (12899)
2012 (13631)
2011 (14410)
2010 (13103)
Location
Africa (571)
Alabama (29)
Alaska (4)
Arizona (87)
Arkansas (5)
Asia (25894)
Australia (4669)
California (3348)
Canada (1139)
China (339)
Colorado (145)
Connecticut (150)
Delaware (92)
Europe (62102)
Florida (508)
Georgia (121)
Hawaii (1)
Idaho (28)
Illinois (275)
India (21)
Indiana (181)
Iowa (6)
Japan (110)
Kansas (59)
Kentucky (15)
Louisiana (7)
Maine (28)
Maryland (620)
Massachusetts (2416)
Michigan (99)
Minnesota (131)
Mississippi (1)
Missouri (48)
Montana (20)
Nebraska (10)
Nevada (34)
New Hampshire (20)
New Jersey (1068)
New Mexico (15)
New York (1022)
North Carolina (489)
North Dakota (4)
Northern California (1537)
Ohio (109)
Oklahoma (6)
Oregon (10)
Pennsylvania (744)
Puerto Rico (4)
Rhode Island (12)
South America (796)
South Carolina (10)
South Dakota (1)
Southern California (1262)
Tennessee (52)
Texas (425)
Utah (75)
Virginia (85)
Washington D.C. (35)
Washington State (284)
West Virginia (2)
Wisconsin (27)
397,149 Results for "alcon grieshaber ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Alcon Secures Majority Stake in Aurion, Deposes CEO
Last month, Deerfield Management accused Alcon of obstructing Aurion’s IPO plans so it could acquire the startup “at a discount.”
March 27, 2025
·
1 min read
·
Tristan Manalac
IPO
‘Valentine’s Day Massacre’: Deerfield Claims Alcon is Blocking Aurion’s IPO
Deerfield Management claims that Alcon Research is seeking a discounted takeover of Aurion Biotech while blocking the startup’s efforts to go public.
February 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Alcon Agrees to Acquire LENSAR, Inc.
March 25, 2025
·
9 min read
Press Releases
Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease
March 27, 2025
·
8 min read
Policy
Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
Sight Sciences, Inc. today announced that it received a positive jury trial verdict of $34 million associated with the patent infringement case it filed on September 16, 2021 against Alcon Inc., Alcon Vision, LLC, Alcon Research, LLC, and Ivantis, Inc.
April 29, 2024
·
6 min read
Press Releases
Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension
February 19, 2025
·
7 min read
Press Releases
Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet
February 24, 2025
·
3 min read
Policy
Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance
Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced that UNITY® Vitreoretinal Cataract System and UNITY® Cataract System have received U.S. Food and Drug Administration 510 clearance.
June 24, 2024
·
6 min read
Press Releases
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference
January 2, 2025
·
1 min read
Business
Alcon Reports Third Quarter 2023 Results
Alcon, the global leader in eye care, reported its financial results for the three and nine months ended September 30, 2023.
November 14, 2023
·
29 min read
1 of 39,715
Next
